Alyse Brennecke
Papers
1
Total Citations
133
H-Index
1
About
Alyse Brennecke is a leading researcher in gynecologic oncology, with a primary focus on optimizing perioperative care and thromboprophylaxis for women with gynecologic malignancies. Her most-cited work, a landmark 2020 study with 133 citations, directly addressed the critical challenge of preventing postoperative venous thromboembolism. By comparing the safety and efficacy of oral apixaban against the standard injectable enoxaparin, Brennecke provided compelling evidence for a more patient-friendly and cost-effective alternative. This research is particularly impactful given the low adherence rates and high costs associated with the traditional 28-day enoxaparin regimen, offering a practical solution that can improve patient outcomes and quality of life. Her work has influenced clinical guidelines and sparked further investigation into simplified anticoagulation protocols. Brennecke’s contributions demonstrate a commitment to translating rigorous clinical data into actionable strategies that directly benefit a vulnerable patient population, solidifying her reputation as a key voice in the evolution of gynecologic cancer care.
Research Focus
Key Achievements
Top Papers
- 1